Century Therapeutics, Inc.

NASDAQ:IPSC

Biotechnology

Healthcare
$1.32 +0.48%

+$0.01 today

Market cap
$239.71M
Beta
1.57
P/E (TTM)
-1.8
EPS (TTM)
-$1.25
52W Low $0.44High $3.04

Volume 0.82M

Average 1.12M

Income Statement

Follow revenue through to earnings.

Revenue

$109.16M

FY 2025 · Annual

+1556.8% YoY

Operating Income

-$15.04M

FY 2025 · Annual

Net Income

-$9.58M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue05.2M2.24M6.59M109.16M
Cost of Revenue4.58M00013.1M
Gross Profit(4.58M)5.2M2.24M6.59M96.06M
Gross Margin—100.0%100.0%100.0%88.0%
Research & Development75.65M97.17M92.71M107.24M95.67M
Selling, General & Admin14.65M31.86M34.71M33.16M24M
Operating Expenses90.3M139.03M148.78M144.73M111.1M
Depreciation & Amortization4.58M8.44M13.04M13.3M13.1M
EBITDA(89.92M)(121.2M)(121.21M)(111.47M)3.45M
EBITDA Margin—-2331.2%-5423.2%-1691.8%3.2%
Operating Income(94.88M)(133.83M)(146.55M)(138.14M)(15.04M)
Operating Margin—-2574.2%-6556.9%-2096.5%-13.8%
Interest Income898K2.99M12.68M13.01M7.35M
Interest Expense1.28M0540K00
Other Income / Expenses(898K)2.99M11.75M13.36M5.39M
Income Before Tax(95.78M)(130.84M)(134.79M)(124.78M)(9.65M)
Pre-Tax Margin—-2516.7%-6031.0%-1893.7%-8.8%
Income Tax Expense43K91K1.88M1.79M(68K)
Net Income(95.82M)(130.93M)(136.67M)(126.57M)(9.58M)
Net Margin—-2518.4%-6115.1%-1920.9%-8.8%
EPS (Basic)(1.74)(2.27)(2.30)(1.61)(0.11)
EPS (Diluted)(1.74)(2.27)(2.30)(1.61)(0.11)
Weighted Avg Shares55.01M57.76M59.31M78.65M86.56M
Weighted Avg Shares (Diluted)55.01M57.76M59.31M78.65M86.56M

IPSC Earnings Waterfall · TTM

NASDAQ:IPSC · Revenue to Net Income

Key Ratios

EPS$-1.25
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$107.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.25, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
8-KCurrent reportOct 2, 2026
4Statement of changes in beneficial ownershipSep 15, 2026

How much revenue does IPSC generate?

Century Therapeutics, Inc. (IPSC) reported $109.16M of revenue in fiscal 2025.

Is IPSC profitable?

Century Therapeutics, Inc. (IPSC) reported -$9.58M of net income, with a net margin of -8.8%.